Sort
48,018 grants matching “immunotherapy”
Immunoengineering Durable Control of HIV Replication
$1,362,935Hans-Peter Kiem · University Of Southern California · P01 · FY2025 · HL
Malaria Parasite Genomics, Development, Drug Resistance, Pathogenesis, and host-parasite interaction
$1,362,488Xinzhuan Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
BIOLOGY AND TRANSPLANTATION OF THE HUMAN STEM CELL
$1,362,444University Of Minnesota Twin Cities · P01 · FY2001 · CA
T cell recognition of the MR1 presented microbial metabolome
$1,362,106Erin June Adams · University Of Chicago · R01 · FY2020 · AI
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,358,469Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
SA-CCRC-Development of Therapeutics and Vaccines Against Coccidioidomycosis.
$1,357,000Chiung-Yu Hung · University Of Texas San Antonio · U19 · FY2022 · AI
SA-CCRC-Development of Therapeutics and Vaccines Against Coccidioidomycosis.
$1,357,000Chiung-Yu Hung · University Of Texas San Antonio · U19 · FY2023 · AI
SA-CCRC-Development of Therapeutics and Vaccines Against Coccidioidomycosis.
$1,357,000Chiung-Yu Hung · University Of Texas San Antonio · U19 · FY2025 · AI
SA-CCRC-Development of Therapeutics and Vaccines Against Coccidioidomycosis.
$1,357,000Chiung-Yu Hung · University Of Texas San Antonio · U19 · FY2024 · AI
Pathogenesis and countermeasures of poxviruses, hemorrhagic fever viruses, MERS
$1,356,966Reed Johnson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Acquired Resistance to Therapy and Iron (ARTI) Center
$1,356,931Boyi Gan · University Of Tx Md Anderson Can Ctr · U54 · FY2023 · CA
Acquired Resistance to Therapy and Iron (ARTI) Center
$1,356,911Boyi Gan · University Of Tx Md Anderson Can Ctr · U54 · FY2025 · CA
Acquired Resistance to Therapy and Iron (ARTI) Center
$1,356,890Boyi Gan · University Of Tx Md Anderson Can Ctr · U54 · FY2022 · CA
Preclinical drug development in pancreatic cancer
$1,356,844Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
SBIR Phase II: Anti-Tumor Immune Redirectors (AIRs) for cancer treatment
$1,355,844Joshua Wang · Verimmune Inc. · · FY2020 · TIP
VANDERBILT ADULT AIDS CLINICAL TRIALS UNIT
$1,355,530Vanderbilt University · U01 · FY2003 · AI
TGIB Surgical Oncology Fellowship Program
$1,353,932David Schrump · Division Of Basic Sciences - Nci · ZIE · FY2015 · CA
Immunobiology and immunotherapy of leukemia
$1,353,837Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
TGIB Surgical Oncology Fellowship Program
$1,353,606David Schrump · Division Of Basic Sciences - Nci · ZIE · FY2017 · CA
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,353,371Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Trial/ efficacy of immunotherapies to control plasma HIV RNA interrup HAART
$1,352,541Weill Medical College Of Cornell Univ · M01 · FY2004 · RR
Protein Expression Facility
$1,352,350Robert Petrovich · National Institute Of Environmental Health Sciences · ZIC · FY2022 · ES
Center for Multiparametric Imaging of Tumor Immune Microenvironments
$1,349,822Paolo Provenzano · University Of Minnesota · U54 · FY2025 · CA
Novel Strategies for Brain Tumor Therapy
$1,349,527University Of Pittsburgh At Pittsburgh · P01 · FY2003 · NS
Heat Shock Protein and Thermal Therapy of Cancer
$1,349,240Roswell Park Cancer Institute Corp · P01 · FY2004 · CA